Attestation requirement for approved bulk drugs removed; prior DCGI or pharmacopeia approval suffices to avoid port-level attestation delays. Export consignments of bulk drugs need not be routed for port-level attestation by Drug Controller officers where the bulk drug is an approved drug, including those listed in the Indian Pharmacopoeia or those approved by the office of the Drug Controller General of India; customs and licensing authorities should not insist on separate attestations at ports, to prevent shipment delays where Drug Controller officers are not stationed.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Attestation requirement for approved bulk drugs removed; prior DCGI or pharmacopeia approval suffices to avoid port-level attestation delays.
Export consignments of bulk drugs need not be routed for port-level attestation by Drug Controller officers where the bulk drug is an approved drug, including those listed in the Indian Pharmacopoeia or those approved by the office of the Drug Controller General of India; customs and licensing authorities should not insist on separate attestations at ports, to prevent shipment delays where Drug Controller officers are not stationed.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
TaxTMI 
